CAM
NBP

Cormorant Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Cormorant Asset Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200,000
Closed -$14.5M – 82
2021
Q3 		$14.5M Buy
+200,000
New +$14.5M 0.59% 43

Other funds holding NBP

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ZAM
Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cormorant Asset Management's NBP Position: Q4 2021 in Review

Cormorant Asset Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2021, closing a stake of 200,000 shares — an estimated $14.5M sold.

Cormorant Asset Management first reported a position in NBP in Q3 2021 and held it in 1 quarter. The position peaked at $14.5M in Q3 2021. 132 funds tracked by Wall St. Rank hold NBP as of Q4 2021.

  • Cormorant Asset Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Cormorant Asset Management sold 200,000 NovaBridge Biosciences American Depositary Shares shares in Q4 2021, an estimated $14.5M.
  • Cormorant Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2021 and held it in 1 quarter.
  • Cormorant Asset Management's NovaBridge Biosciences American Depositary Shares position peaked at $14.5M in Q3 2021.
  • 132 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2021.

Based on Cormorant Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.